
NHI Stock Forecast & Price Target
NHI Analyst Ratings
Bulls say
National Health Investors Inc. has demonstrated a strong financial performance, prompting an increase in normalized Funds From Operations (NFFO) estimates for 2025 to $4.80 per share, which aligns with management's guidance range. The company’s success in exceeding earnings expectations in the second quarter of 2025 and providing an encouraging outlook has contributed to a positive sentiment around its performance. Additionally, the 2026 FFO estimate has been raised to $5.03 per share, slightly exceeding the consensus, further solidifying the optimistic outlook for the company's financial trajectory.
Bears say
National Health Investors Inc is facing a negative outlook primarily due to anticipated lower earnings growth over the coming years, reflecting operational challenges related to operator transitions and potential rent resets. The company's financial performance may further suffer if deferred rent collections are weaker than expected, or if specific operators encounter difficulties, particularly in light of uncertainties surrounding health crises. These factors collectively underscore significant risks to the company's revenue stability and overall financial health.
This aggregate rating is based on analysts' research of National Health Investors and is not a guaranteed prediction by Public.com or investment advice.
NHI Analyst Forecast & Price Prediction
Start investing in NHI
Order type
Buy in
Order amount
Est. shares
0 shares